Wegovy and similar medicines, which belong to a class of drugs known as GLP-1 receptor agonists, can cost more than US$1,000 per month, and may require extended use to yield significant benefits
There is currently limited scientific evidence that IV infusions provide general health, "wellness", energy, immune, detox or anti-ageing benefits in people who do not have a diagnosed deficiency or medical need, and we cannot guarantee any particular result individual responses vary
Switching between semaglutide concentrations safely At some point, most semaglutide users switch concentrations
People with a personal or family history of medullary thyroid cancer, or a condition called MEN2, should not use either drug